Ajay Agrawal - Genpact Independent Director

G Stock  USD 31.59  0.70  2.27%   

Director

Mr. Ajay Agrawal is Director of the Company. He is currently the Geoffrey Taber Chair in Entrepreneurship and Innovation and Professor of Strategic Management at the University of Torontos Rotman School of Management, where he has served on the faculty since 2003. Prior to 2003, Mr. Agrawal served as an assistant professor at Queens University. In 2012, he founded and currently serves as academic director of the Rotman School of Managements Creative Destruction Lab, where he oversees operations across multiple cities in Canada and the United States to help incubate businesses that apply artificial intelligence and other technologies to commercial applications. Mr. Agrawal is also the cofounder of Kindred AI, a company that makes artificial intelligence for robots. since 2019.
Age 51
Tenure 5 years
Address Canon's, Court, Hamilton, Bermuda, HM 12
Phone441 298 3300
Webhttps://www.genpact.com

Ajay Agrawal Latest Insider Activity

Tracking and analyzing the buying and selling activities of Ajay Agrawal against Genpact stock is an integral part of due diligence when investing in Genpact. Ajay Agrawal insider activity provides valuable insight into whether Genpact is net buyers or sellers over its current business cycle. Note, Genpact insiders must abide by specific rules, including filing SEC forms every time they buy or sell Genpact'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Genpact Management Efficiency

The company has return on total asset of 0.083 % which means that for every 100 dollars spent on assets, it generated a profit of $0.083. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3099 %, implying that it made 0.3099 on every $100 invested by shareholders. Genpact's management efficiency ratios could be used to measure how well Genpact manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Genpact's Return On Equity is most likely to increase slightly in the upcoming years. At this time, Genpact's Intangibles To Total Assets are most likely to slightly decrease in the upcoming years. The Genpact's current Return On Assets is estimated to increase to 0.14, while Other Assets are projected to decrease to 0.95.
The company has accumulated 1.5 B in total debt with debt to equity ratio (D/E) of 1.04, which looks OK as compared to the sector. Genpact Limited has a current ratio of 1.55, which is considered satisfactory as compared to similar companies. Debt can assist Genpact until it has trouble settling it off, either with new capital or with free cash flow. So, Genpact's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genpact Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genpact to invest in growth at high rates of return. When we think about Genpact's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Barry AllenCDW Corp
69
Michael DominguezCDW Corp
45
Thomas FristScience Applications Internatio
47
David LundeenPerficient
56
Garth GrahamScience Applications Internatio
45
Katharina McFarlandScience Applications Internatio
61
Marty KittrellASGN Inc
63
Mariel JolietASGN Inc
54
David NelmsCDW Corp
57
Mark FrantzASGN Inc
50
Charles RevoileCACI International
85
John HamreScience Applications Internatio
69
Marie JolietASGN Inc
49
John HamlinPerficient
48
Warren PhillipsCACI International
78
William JewsCACI International
68
Virginia AlbaneseCDW Corp
51
Brian CallaghanASGN Inc
49
Edwin SheridanASGN Inc
50
James GilmoreCACI International
67
James PavittCACI International
74
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. The company was founded in 1997 and is based in Hamilton, Bermuda. Genpact is traded on New York Stock Exchange in the United States. Genpact Limited (G) is traded on New York Stock Exchange in USA. It is located in Canon's, Court, Hamilton, Bermuda, HM 12 and employs 129,100 people. Genpact is listed under Data Processing & Outsourced Services category by Fama And French industry classification.

Management Performance

Genpact Limited Leadership Team

Elected by the shareholders, the Genpact's board of directors comprises two types of representatives: Genpact inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genpact. The board's role is to monitor Genpact's management team and ensure that shareholders' interests are well served. Genpact's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genpact's outside directors are responsible for providing unbiased perspectives on the board's policies.
Piyush Mehta, Chief Human Resources Officer, Senior Vice President
Edward Fitzpatrick, Chief Financial Officer, Senior Vice President
CFA CFA, VP CFO
Carol Lindstrom, Independent Director
Kathryn Stein, Senior Vice President, Chief Strategy Officer and Global Business Leader, Enterprise Services
Edward CPA, Senior Advisor
Nallicheri Tyagarajan, CEO President
Krista Bessinger, Head Relations
Jim Madden, Independent Director
Brian Stevens, Independent Director
CeCe Morken, Director
Kevin Webb, Head Services
Michael CFA, Senior CFO
Laura Conigliaro, Independent Director
Tamara Franklin, Independent Director
Ezra Baylin, Head Acquisitions
Hailey Eichner, Chief CEO
Victor Guaglianone, Senior Vice President General Counsel, Corporate Secretary
CeCelia Morken, Independent Director
Mark Verdi, Independent Director
Vipin Gairola, Global Officer
Hanspeter Spek, Independent Director
Darren Saumur, Senior Vice President Global Operating Officer
Sameer Dewan, Senior Leader
Patrick Cogny, Senior Vice President - Infrastructure, Manufacturing & Services and High Tech
Robert Scott, Independent Non-Executive Chairman of the Board
Mohit Thukral, Sr. VP of Banking, Financial Services and Insurance
Ahmed Mazhari, Senior Vice President Chief Growth Officer
Ajay Agrawal, Independent Director
Michael Weiner, Chief Financial Officer, Senior Vice President
Roger CFA, Head Relations
Alex Mandl, Independent Director
Balkrishan Kalra, Senior Vice President - Banking, Capital Markets, Consumer Goods, Retail, Life Sciences and Healthcare
Heather White, Senior Vice President, Chief Legal Officer, Corporate Secretary
Vidya Rao, Chief Officer
N Tyagarajan, President, Chief Executive Officer, Director
Anil Nanduru, Consumer Manufacturing
Stacey Cartwright, Independent Director
Donald Klunk, Chief Officer
Mohit Bhatia, Sr. VP and Internal Transformation Leader
Rajiv Naidu, Business Affairs
Mark Nunnelly, Independent Director
James Madden, Non-Executive Independent Chairman of the Board
Caitlin Blewett, Chief Officer
Riju Vashisht, Chief Officer
Arvinder Singh, Sr. VP and Bus. Leader of Capital Markets and IT Services
Amit Chandra, Independent Director
David Humphrey, Independent Director

Genpact Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genpact a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Genpact Investors Sentiment

The influence of Genpact's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Genpact. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Genpact's public news can be used to forecast risks associated with an investment in Genpact. The trend in average sentiment can be used to explain how an investor holding Genpact can time the market purely based on public headlines and social activities around Genpact Limited. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Genpact's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Genpact's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Genpact's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Genpact.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genpact in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genpact's short interest history, or implied volatility extrapolated from Genpact options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Genpact Limited is a strong investment it is important to analyze Genpact's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genpact's future performance. For an informed investment choice regarding Genpact Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.311
Dividend Share
0.55
Earnings Share
3.41
Revenue Per Share
24.552
Quarterly Revenue Growth
0.04
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.